# Nutraceutical Composition Containing Natural Products Derivatives on the Modulation of the Endocrine Neuroimmune Axis

> **NCT04810572** · NA · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 162 (actual)

## Conditions studied

- Insulin Resistance
- Inflammatory Bowel Diseases
- Overweight and Obesity
- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** Composition with Silymarin
- **DIETARY_SUPPLEMENT:** Low-mineral composition without Silymarin

## Key facts

- **NCT ID:** NCT04810572
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-20
- **Primary completion:** 2022-05-20
- **Final completion:** 2022-12-19
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2024-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04810572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04810572, "Nutraceutical Composition Containing Natural Products Derivatives on the Modulation of the Endocrine Neuroimmune Axis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04810572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*